| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract related to PL-22 Guidelines for antithrombotics in cancer patients
|
Farge-Bancel, D.
|
|
2012
|
129 |
S1 |
p. S194-
1 p.
|
artikel
|
| 2 |
Accounting for death as a competing risk in cancer-associated thrombosis studies
|
Campigotto, Federico
|
|
2012
|
129 |
S1 |
p. S85-S87
3 p.
|
artikel
|
| 3 |
Acquired hemophilia in malignancy
|
Reeves, Brandi N.
|
|
2012
|
129 |
S1 |
p. S66-S68
3 p.
|
artikel
|
| 4 |
Alternatively spliced tissue factor triggers breast tumor growth
|
Kocatürk, B.
|
|
2012
|
129 |
S1 |
p. S168-S169
2 p.
|
artikel
|
| 5 |
Apoptosis in CHO-K1 cells overexpressing TFPI involves both intrinsic and extrinsic pathways additional to induced activation of NFκB
|
Skretting, G.
|
|
2012
|
129 |
S1 |
p. S192-
1 p.
|
artikel
|
| 6 |
A pulmonary severity index (PESI)-based competency that underpins a modular outpatient nurse lead PE (pulmonary embolism) service for cancer patients
|
Palmer, J.
|
|
2012
|
129 |
S1 |
p. S182-
1 p.
|
artikel
|
| 7 |
Are high D-Dimer levels in patients with acute VTE a sign of possible occult cancer?
|
Cavazza, S.
|
|
2012
|
129 |
S1 |
p. S163-
1 p.
|
artikel
|
| 8 |
Argatroban for treatment of vein thrombosis complicating heparin-induced thrombocytopenia in haemodialyzed multiple myeloma: a case report
|
Pierfranceschi, M. Giorgi
|
|
2012
|
129 |
S1 |
p. S178-S179
2 p.
|
artikel
|
| 9 |
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
|
Gary, T.
|
|
2012
|
129 |
S1 |
p. S181-
1 p.
|
artikel
|
| 10 |
Author Index
|
|
|
2012
|
129 |
S1 |
p. S195-S198
4 p.
|
artikel
|
| 11 |
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism
|
Kleinjan, A.
|
|
2012
|
129 |
S1 |
p. S183-
1 p.
|
artikel
|
| 12 |
Binding of anti-GRP78 autoantibodies to cell surface GRP78 promotes cancer progression by activating tissue factor procoagulant activity
|
Al-Hashimi, A.A.
|
|
2012
|
129 |
S1 |
p. S158-
1 p.
|
artikel
|
| 13 |
Bleeding complications in patients with CKD and malignancy during anticoagulant treatment for venous thromboembolism
|
Kooiman, J.
|
|
2012
|
129 |
S1 |
p. S157-
1 p.
|
artikel
|
| 14 |
Breast cancer and comorbidity and risk of venous thromboembolism: a Danish nationwide population based cohort study
|
Ording, A.G.
|
|
2012
|
129 |
S1 |
p. S167-
1 p.
|
artikel
|
| 15 |
Calibrated automated thrombogram for determination of ATIII function
|
Kolyadko, N.N.
|
|
2012
|
129 |
S1 |
p. S189-
1 p.
|
artikel
|
| 16 |
Cancer cells modify the microenvironment: RGS5, a novel endothelial protein of the abnormal tumor vasculature
|
Figini, S.
|
|
2012
|
129 |
S1 |
p. S193-
1 p.
|
artikel
|
| 17 |
Cancer in pregnancy: The role of thromboprophylaxis
|
Brenner, Benjamin
|
|
2012
|
129 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 18 |
Cancer-related differences in morpho-functional status of peripheral blood platelets
|
Vasilenko, I.
|
|
2012
|
129 |
S1 |
p. S175-
1 p.
|
artikel
|
| 19 |
Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients
|
Kleinjan, A.
|
|
2012
|
129 |
S1 |
p. S161-
1 p.
|
artikel
|
| 20 |
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma
|
Sartori, M.T.
|
|
2012
|
129 |
S1 |
p. S171-S172
2 p.
|
artikel
|
| 21 |
Comparison of microparticle subsets and procoagulant properties in polycythemia vera and essential thrombocythemia
|
Trappenburg, M.C.
|
|
2012
|
129 |
S1 |
p. S189-
1 p.
|
artikel
|
| 22 |
Cryogenic- and room-temperature electron microscopy imaging of MDA231 breast cancer cells and microparticles using immunogold labeling
|
Issman, L.
|
|
2012
|
129 |
S1 |
p. S168-
1 p.
|
artikel
|
| 23 |
Current concepts in the management of disseminated intravascular coagulation
|
Thachil, Jecko
|
|
2012
|
129 |
S1 |
p. S54-S59
6 p.
|
artikel
|
| 24 |
CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
|
Sandset, Per Morten
|
|
2012
|
129 |
S1 |
p. S97-S100
4 p.
|
artikel
|
| 25 |
Differential response of acute phase markers in lymphoid leukaemias – a probable diagnostic tool
|
Ajayi, O.I.
|
|
2012
|
129 |
S1 |
p. S173-
1 p.
|
artikel
|
| 26 |
Does comorbidity interact with colon cancer to increase the risk of venous thromboembolism?
|
Erichsen, R.
|
|
2012
|
129 |
S1 |
p. S164-
1 p.
|
artikel
|
| 27 |
Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients?
|
Saadeh, F. Abu
|
|
2012
|
129 |
S1 |
p. S170-
1 p.
|
artikel
|
| 28 |
E-alerts for the prevention of venous thromboembolism in onco-hematological inpatients: pilot evaluation of reasons for physicians' refusal of pharmacological thromboprophylaxis
|
Lazo, C.
|
|
2012
|
129 |
S1 |
p. S181-
1 p.
|
artikel
|
| 29 |
Effect of heparins on thrombin generation and proangiogenic properties of breast tumor cells
|
Diani, E.
|
|
2012
|
129 |
S1 |
p. S180-
1 p.
|
artikel
|
| 30 |
Elevated markers of hemostasis, fibrinolysis and angiogenesis in patients with advanced prostate cancer decrease following hormonal therapy in responding patients
|
Arnason, J.E.
|
|
2012
|
129 |
S1 |
p. S175-
1 p.
|
artikel
|
| 31 |
Endothelial cell activation markers in cancer
|
Blann, Andrew D.
|
|
2012
|
129 |
S1 |
p. S122-S126
5 p.
|
artikel
|
| 32 |
Esophageal variceal bleeding as a potential marker of liver cancer in patients with liver cirrhosis
|
Montomoli, J.
|
|
2012
|
129 |
S1 |
p. S166-
1 p.
|
artikel
|
| 33 |
Evaluation of assay performance monitoring direct thrombin inhibitors with TECHNOCLOT® DTI
|
Leitner, M.
|
|
2012
|
129 |
S1 |
p. S187-
1 p.
|
artikel
|
| 34 |
Evaluation of assay performance monitoring Rivaroxaban with TECHNOCHROM anti-Xa on different analyzers
|
Leitner, M.
|
|
2012
|
129 |
S1 |
p. S187-
1 p.
|
artikel
|
| 35 |
Evaluation of platelet function and thromboxane A2 production in aspirin-treated patients with essential thrombocythemia
|
Lussana, F.
|
|
2012
|
129 |
S1 |
p. S157-S158
2 p.
|
artikel
|
| 36 |
Evaluation of the efficacy of use of fibrinogen in acquired coagulopathies
|
Marcos, J. Martinez
|
|
2012
|
129 |
S1 |
p. S177-
1 p.
|
artikel
|
| 37 |
Evidence that protease-activated receptor-2 (PAR-2) supports angiogenesis in a murine melanoma model
|
Oliveira, A.
|
|
2012
|
129 |
S1 |
p. S192-
1 p.
|
artikel
|
| 38 |
Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis
|
Spiezia, L.
|
|
2012
|
129 |
S1 |
p. S174-
1 p.
|
artikel
|
| 39 |
Fibrinogen-like protein 2 (FGL-2) – a novel biomarker for cancer
|
Rabizadeh, E.
|
|
2012
|
129 |
S1 |
p. S192-
1 p.
|
artikel
|
| 40 |
Follow up of thrombin-generation after prostate cancer surgery
|
Benyo, M.
|
|
2012
|
129 |
S1 |
p. S190-
1 p.
|
artikel
|
| 41 |
Functional activity of natural anticoagulants in children with acute lymphoblastic leukemia during treatment
|
Lipay, N.V.
|
|
2012
|
129 |
S1 |
p. S188-
1 p.
|
artikel
|
| 42 |
Genetic pathways linking hemostasis and cancer
|
Garnier, Delphine
|
|
2012
|
129 |
S1 |
p. S22-S29
8 p.
|
artikel
|
| 43 |
Hemorrhagic diathesis in a patient with multiple myeloma – case report
|
Bartosová, L.
|
|
2012
|
129 |
S1 |
p. S174-S175
2 p.
|
artikel
|
| 44 |
Hemostatic factors, innate immunity and malignancy
|
Degen, Jay L.
|
|
2012
|
129 |
S1 |
p. S1-S5
5 p.
|
artikel
|
| 45 |
Heparanase procoagulant activity
|
Nadir, Yona
|
|
2012
|
129 |
S1 |
p. S76-S79
4 p.
|
artikel
|
| 46 |
Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel
|
Wang, J.G.
|
|
2012
|
129 |
S1 |
p. S171-
1 p.
|
artikel
|
| 47 |
Hypoxia induces Smad2 phosphorylation signaling and increases stem cell-like properties and multi-drug resistance in K562 leukemic cells
|
Cui, X.-Y.
|
|
2012
|
129 |
S1 |
p. S191-S192
2 p.
|
artikel
|
| 48 |
Immunomodulatory effects of vitamin K-antagonist acenocoumarol
|
Schroecksnadel, S.
|
|
2012
|
129 |
S1 |
p. S176-
1 p.
|
artikel
|
| 49 |
Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung
|
Papageorgiou, C.
|
|
2012
|
129 |
S1 |
p. S188-S189
2 p.
|
artikel
|
| 50 |
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer
|
Vedovati, M.C.
|
|
2012
|
129 |
S1 |
p. S162-
1 p.
|
artikel
|
| 51 |
Induction of apoptosis and tissue factor (TF) expression in germ cell tumor cell lines by cisplatin chemotherapy
|
Jacobsen, C.
|
|
2012
|
129 |
S1 |
p. S169-
1 p.
|
artikel
|
| 52 |
Inhibition of FGF-2 angiogenic activity by novel small molecules mimetic of thrombospondin-1 (TSP-1)
|
Foglieni, C.
|
|
2012
|
129 |
S1 |
p. S193-
1 p.
|
artikel
|
| 53 |
Intercellular transfer of tissue factor upon the uptake of tumor-derived microvesicles
|
Lima, L.G.
|
|
2012
|
129 |
S1 |
p. S172-
1 p.
|
artikel
|
| 54 |
International registry on the treatment of unsuspected pulmonary embolism in cancer patients
|
Di Nisio, M.
|
|
2012
|
129 |
S1 |
p. S186-
1 p.
|
artikel
|
| 55 |
Interplay of tissue factor splice variants in thrombosis
|
Tieken, C.
|
|
2012
|
129 |
S1 |
p. S169-
1 p.
|
artikel
|
| 56 |
In vitro antioxidant and antitumor evaluation of new sulfated antithrombotic small molecules
|
Correia-da-Silva, M.
|
|
2012
|
129 |
S1 |
p. S179-S180
2 p.
|
artikel
|
| 57 |
In vivo cleavage of protein S is a major determinant in thrombin generation and correlates with platelet count in individuals with hematological malignancies
|
Brinkman, H.J.M.
|
|
2012
|
129 |
S1 |
p. S188-
1 p.
|
artikel
|
| 58 |
Involvement of tissue factor expressed by cancer cells on tumor growth and thrombosis associated with cancer
|
Mezouar, S.
|
|
2012
|
129 |
S1 |
p. S169-S170
2 p.
|
artikel
|
| 59 |
Khorana risk score and PROTECHT risk score as prediction models of venous thromboembolism in cancer outpatients receiving chemotherapy: a retrospective analysis
|
Barni, S.
|
|
2012
|
129 |
S1 |
p. S166-
1 p.
|
artikel
|
| 60 |
Long term clinical outcomes of cancer associated venous thromboembolism: findings from the MASTER registry
|
Imberti, D.
|
|
2012
|
129 |
S1 |
p. S163-
1 p.
|
artikel
|
| 61 |
Low-molecular-weight heparin and survival in lung cancer
|
Noble, Simon
|
|
2012
|
129 |
S1 |
p. S114-S118
5 p.
|
artikel
|
| 62 |
Measurement of the new anticoagulants
|
Harenberg, Job
|
|
2012
|
129 |
S1 |
p. S106-S113
8 p.
|
artikel
|
| 63 |
Mechanisms coupling thrombomodulin to tumor dissemination
|
Horowitz, Netanel A.
|
|
2012
|
129 |
S1 |
p. S119-S121
3 p.
|
artikel
|
| 64 |
Microparticles in tumor progression
|
Falanga, Anna
|
|
2012
|
129 |
S1 |
p. S132-S136
5 p.
|
artikel
|
| 65 |
Monocyte count associates with subsequent symptomatic venous thromboembolism (VTE) in hospitalized patients with solid tumors
|
Rojnuckarin, P.
|
|
2012
|
129 |
S1 |
p. S172-
1 p.
|
artikel
|
| 66 |
New and old anticoagulants in cancer
|
Verso, Melina
|
|
2012
|
129 |
S1 |
p. S101-S105
5 p.
|
artikel
|
| 67 |
New antithrombotic agents in the treatment of VTE; a subgroup analysis of the Phase III randomized clinical trials
|
Gerotziafas, G.T.
|
|
2012
|
129 |
S1 |
p. S160-
1 p.
|
artikel
|
| 68 |
New potential markers of severe thrombo-hemorrhagic syndrome (THS) in acute promyelocytic leukemia (APL) patients: activated FVII-antithrombin complex (FVIIa-AT) and Tissue Factor (TF) mRNA
|
Marchetti, M.
|
|
2012
|
129 |
S1 |
p. S159-
1 p.
|
artikel
|
| 69 |
Novel approaches in the detection of binding of cancer cell microparticles to activated platelets
|
Bradford, R.L.
|
|
2012
|
129 |
S1 |
p. S190-
1 p.
|
artikel
|
| 70 |
Novel functions of TFPI isoforms in breast cancer cells
|
Stavik, B.
|
|
2012
|
129 |
S1 |
p. S156-S157
2 p.
|
artikel
|
| 71 |
Oncogenic regulation of tissue factor and thrombosis in cancer
|
Anand, Monika
|
|
2012
|
129 |
S1 |
p. S46-S49
4 p.
|
artikel
|
| 72 |
On the use of anti-platelet drugs to diminish both tumor growth and thrombosis
|
Darbousset, R.
|
|
2012
|
129 |
S1 |
p. S160-S161
2 p.
|
artikel
|
| 73 |
Orally administered unfractionated heparin reduces lung tumour incidence in a rat model
|
Hiebert, L.
|
|
2012
|
129 |
S1 |
p. S177-S178
2 p.
|
artikel
|
| 74 |
Outcome and characteristics of cancer patients with unsuspected PE managed under a specialised care pathway protocol – updated results
|
Maraveyas, A.
|
|
2012
|
129 |
S1 |
p. S183-
1 p.
|
artikel
|
| 75 |
Outpatient management of pulmonary embolism in cancer patients: data on a prospective cohort with 138 consecutive patients
|
Font, C.
|
|
2012
|
129 |
S1 |
p. S184-
1 p.
|
artikel
|
| 76 |
PAR-2 activation induces migration but not proliferation of pancreatic cancer cells
|
Shi, K.
|
|
2012
|
129 |
S1 |
p. S191-
1 p.
|
artikel
|
| 77 |
Peripheral blood microparticle-associated tissue factor activity in stage III and IV lung cancer
|
Martino, F.
|
|
2012
|
129 |
S1 |
p. S171-
1 p.
|
artikel
|
| 78 |
Plasma vascular cell adhesion molecule 1, intercellular adhesion molecule 1 and osteoprotegerin levels in rectal cancer patients exposed to preoperative radiotherapy: a clinical prospective cohort study
|
Stender, M.T.
|
|
2012
|
129 |
S1 |
p. S174-
1 p.
|
artikel
|
| 79 |
Platelet CLEC-2 and podoplanin in cancer metastasis
|
Lowe, Kate L.
|
|
2012
|
129 |
S1 |
p. S30-S37
8 p.
|
artikel
|
| 80 |
Platelets dysfunction in multiple myeloma
|
Djunic, I.
|
|
2012
|
129 |
S1 |
p. S173-
1 p.
|
artikel
|
| 81 |
Platelet systems biology using integrated genetic and proteomic platforms
|
Bahou, Wadie F.
|
|
2012
|
129 |
S1 |
p. S38-S45
8 p.
|
artikel
|
| 82 |
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients
|
Ay, Cihan
|
|
2012
|
129 |
S1 |
p. S6-S9
4 p.
|
artikel
|
| 83 |
Preface
|
Falanga, Anna
|
|
2012
|
129 |
S1 |
p. ix-
1 p.
|
artikel
|
| 84 |
Preoperative D-dimer levels predict long-term disease-free survival in patients with curatively intended resection for stage III colorectal cancer: a prospective cohort study
|
Sunesen, K.G.
|
|
2012
|
129 |
S1 |
p. S167-
1 p.
|
artikel
|
| 85 |
Preoperative preparation in prophylaxis of thrombotic complications in cancer patients
|
Vorobev, A.V.
|
|
2012
|
129 |
S1 |
p. S185-
1 p.
|
artikel
|
| 86 |
Prevalence of pulmonary embolism in colorectal cancer at time of diagnosis
|
Poulsen, M.
|
|
2012
|
129 |
S1 |
p. S165-
1 p.
|
artikel
|
| 87 |
Prevalence of unexpected pulmonary embolism at CT scan for cancer staging in patients with lung cancer
|
Verso, M.
|
|
2012
|
129 |
S1 |
p. S167-S168
2 p.
|
artikel
|
| 88 |
Primary VTE prophylaxis in ambulatory cancer patients receiving chemotherapy – a cost analysis
|
Rossi, A.
|
|
2012
|
129 |
S1 |
p. S185-S186
2 p.
|
artikel
|
| 89 |
Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy
|
Saadeh, F. Abu
|
|
2012
|
129 |
S1 |
p. S189-S190
2 p.
|
artikel
|
| 90 |
Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines
|
Dutra-Oliveira, A.
|
|
2012
|
129 |
S1 |
p. S190-S191
2 p.
|
artikel
|
| 91 |
Rate and time course of thromboembolism events in cancer patients
|
Hull, R.
|
|
2012
|
129 |
S1 |
p. S163-
1 p.
|
artikel
|
| 92 |
Rate of venous thromboembolism by cancer type compared to the general population using multiple linked databases
|
Walker, A.J.
|
|
2012
|
129 |
S1 |
p. S155-S156
2 p.
|
artikel
|
| 93 |
Risk and management of thrombosis in multiple myeloma
|
Leebeek, Frank W.G.
|
|
2012
|
129 |
S1 |
p. S88-S92
5 p.
|
artikel
|
| 94 |
Risk assessment for cancer-associated thrombosis: What is the best approach?
|
Khorana, Alok A.
|
|
2012
|
129 |
S1 |
p. S10-S15
6 p.
|
artikel
|
| 95 |
Risk of venous thromboembolism after hospitalisation with cancer: record linkage study
|
Arjinian, S.
|
|
2012
|
129 |
S1 |
p. S184-S185
2 p.
|
artikel
|
| 96 |
Role of anticoagulant heparan sulfate in tumor angiogenesis of the uterine carcinoma
|
de Agostini, A.
|
|
2012
|
129 |
S1 |
p. S180-S181
2 p.
|
artikel
|
| 97 |
Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression
|
Resovi, A.
|
|
2012
|
129 |
S1 |
p. S193-
1 p.
|
artikel
|
| 98 |
Safety and efficacy of an educational program in reducing thrombotic and infective complications of peripherally inserted central catheters (PICCs) in haematological patients
|
Malato, A.
|
|
2012
|
129 |
S1 |
p. S176-S177
2 p.
|
artikel
|
| 99 |
Screening for occult malignancy with 18-F-FDG-PET/CT in patients with unprovoked venous thromboembolism
|
Alfonso, A.
|
|
2012
|
129 |
S1 |
p. S176-
1 p.
|
artikel
|
| 100 |
Severity-of-illness in cancer patients contributes to the risk of hospital-acquired venous thromboembolism (VTE), but not post-discharge VTE
|
Kaatz, S.
|
|
2012
|
129 |
S1 |
p. S166-S167
2 p.
|
artikel
|
| 101 |
Side effects of anti-angiogenic drugs
|
Elice, Francesca
|
|
2012
|
129 |
S1 |
p. S50-S53
4 p.
|
artikel
|
| 102 |
Soluble endothelial protein C receptor (sEPCR) and coagulation parameters as prognostic factors in advanced non small cell lung cancer (NSCLC)
|
Sarig, G.
|
|
2012
|
129 |
S1 |
p. S173-S174
2 p.
|
artikel
|
| 103 |
Splanchnic vein thrombosis: new risk factors and management
|
Donadini, Marco P.
|
|
2012
|
129 |
S1 |
p. S93-S96
4 p.
|
artikel
|
| 104 |
Standardized TGA measurement on the coagulation analyzer Ceveron® alpha TGA with the new optimized fluorogenic module
|
Bindert, B.R.
|
|
2012
|
129 |
S1 |
p. S186-S187
2 p.
|
artikel
|
| 105 |
Structure of congenital and acquired thrombophilia in cancer patients with thrombotic complication in past history
|
Vorobev, A.V.
|
|
2012
|
129 |
S1 |
p. S175-S176
2 p.
|
artikel
|
| 106 |
Studying cell-microenvironment interactions in a microfluidics model of tumor microcirculation
|
Demou, Z.N.
|
|
2012
|
129 |
S1 |
p. S158-S159
2 p.
|
artikel
|
| 107 |
T cells, tissue factor and malignancy
|
D'Elios, M.M.
|
|
2012
|
129 |
S1 |
p. S168-
1 p.
|
artikel
|
| 108 |
Testing for and treating cancer associated thrombosis: choice of anticoagulant
|
Johnson, M.J.
|
|
2012
|
129 |
S1 |
p. S179-
1 p.
|
artikel
|
| 109 |
The effect of aspirin on cancer mortality
|
Meade, T.
|
|
2012
|
129 |
S1 |
p. S160-
1 p.
|
artikel
|
| 110 |
The effect of malignancy and chemotherapy on thrombin generation in cancer patients
|
Rahman, A.H.B.
|
|
2012
|
129 |
S1 |
p. S187-
1 p.
|
artikel
|
| 111 |
The pathogenesis of warfarin-associated venous limb ischemia and gangrene complicating cancer: clinical and laboratory parallels with heparin-induced thrombocytopenia (HIT)
|
Warkentin, T.E.
|
|
2012
|
129 |
S1 |
p. S159-S160
2 p.
|
artikel
|
| 112 |
The procoagulant response to cancer surgery is increased in early breast cancer with poor prognosis phenotypes
|
Shaker, H.
|
|
2012
|
129 |
S1 |
p. S172-S173
2 p.
|
artikel
|
| 113 |
The protein C pathway in cancer metastasis
|
Spek, C. Arnold
|
|
2012
|
129 |
S1 |
p. S80-S84
5 p.
|
artikel
|
| 114 |
The role of breast cancer cell microparticles in thrombogenicity and angiogenesis following chemotherapy
|
Aharon, A.
|
|
2012
|
129 |
S1 |
p. S170-S171
2 p.
|
artikel
|
| 115 |
The role of 18-fluorine-fluorodeoxyglucose positron emission tomography in the evaluation of deep vein thrombosis
|
Rondina, M.T.
|
|
2012
|
129 |
S1 |
p. S165-S166
2 p.
|
artikel
|
| 116 |
The value of thoraco-abdominal CT scanning for the detection of occult cancer in patients with unprovoked venous thromboembolism. A randomized study
|
Piccioli, A.
|
|
2012
|
129 |
S1 |
p. S164-
1 p.
|
artikel
|
| 117 |
Thrombin induces pancreatic cancer cell survival during growth factor deprivation
|
Queiroz, K.C.S.
|
|
2012
|
129 |
S1 |
p. S191-
1 p.
|
artikel
|
| 118 |
Thromboembolic complications in children with cancer: data from the Italian registry of childhood thrombosis (RITI)
|
Putti, M.C.
|
|
2012
|
129 |
S1 |
p. S156-
1 p.
|
artikel
|
| 119 |
Thrombophilia in oncology patients: hypercoagulability evaluation and assessment of anticoagulant prophylaxis
|
Sukhanov, V.A.
|
|
2012
|
129 |
S1 |
p. S178-
1 p.
|
artikel
|
| 120 |
Thromboprophylaxis in non-surgical cancer patients
|
Cohen, Alexander T.
|
|
2012
|
129 |
S1 |
p. S137-S145
9 p.
|
artikel
|
| 121 |
Thrombotic superior vena cava syndrome in cancer patients: data from a single center cohort of 340 consecutive patients
|
Reig, O.
|
|
2012
|
129 |
S1 |
p. S181-
1 p.
|
artikel
|
| 122 |
Tissue factor isoforms in cancer and coagulation: May the best isoform win
|
Kocatürk, Begüm
|
|
2012
|
129 |
S1 |
p. S69-S75
7 p.
|
artikel
|
| 123 |
Tissue factor proangiogenic signaling in cancer progression
|
Schaffner, Florence
|
|
2012
|
129 |
S1 |
p. S127-S131
5 p.
|
artikel
|
| 124 |
Transfusion issues in cancer patients
|
Federici, Augusto B.
|
|
2012
|
129 |
S1 |
p. S60-S65
6 p.
|
artikel
|
| 125 |
Treatment of established thrombotic events in patients with cancer
|
Lee, Agnes Y.Y.
|
|
2012
|
129 |
S1 |
p. S146-S153
8 p.
|
artikel
|
| 126 |
TrypsinogenIV, a new player in tumor angiogenesis
|
Ghilardi, C.
|
|
2012
|
129 |
S1 |
p. S156-
1 p.
|
artikel
|
| 127 |
Unsuspected pulmonary embolism in patients with cancer
|
Soler, Silvia
|
|
2012
|
129 |
S1 |
p. S16-S19
4 p.
|
artikel
|
| 128 |
Upregulation of tissue factor expression by avastin: ex vivo and in vitro data
|
Napoleone, E.
|
|
2012
|
129 |
S1 |
p. S170-
1 p.
|
artikel
|
| 129 |
Use of low-molecular-weight heparins in cancer patients with renal impairment: a review
|
Rey, J-B.
|
|
2012
|
129 |
S1 |
p. S184-
1 p.
|
artikel
|
| 130 |
Use of recombinant activated factor VII in the treatment of bleeding in chemotherapy induced thrombocytopenia
|
Kubisz, P.
|
|
2012
|
129 |
S1 |
p. S179-
1 p.
|
artikel
|
| 131 |
Use of vena cava filters in cancer patients in California
|
White, R.H.
|
|
2012
|
129 |
S1 |
p. S161-S162
2 p.
|
artikel
|
| 132 |
Variability of INR in a sample of cancer patients in the WARP trial
|
Young, A.
|
|
2012
|
129 |
S1 |
p. S186-
1 p.
|
artikel
|
| 133 |
Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy
|
Papageorgiou, C.
|
|
2012
|
129 |
S1 |
p. S182-
1 p.
|
artikel
|
| 134 |
Venous thromboembolism and haemostatic disturbances in patients with upper gastrointestinal cancer
|
Larsen, A.C.
|
|
2012
|
129 |
S1 |
p. S165-
1 p.
|
artikel
|
| 135 |
Venous thromboembolism in cancer patients
|
Sawant, S.
|
|
2012
|
129 |
S1 |
p. S182-
1 p.
|
artikel
|
| 136 |
Venous thromboembolism: the interaction between prostate cancer and comorbidities and its impact on prognosis
|
Nguyen-Nielsen, M.
|
|
2012
|
129 |
S1 |
p. S164-
1 p.
|
artikel
|
| 137 |
Vitamin K antagonists versus LMWH in the treatment of venous thromboembolism in patients with malignancy: an observational survey in daily clinical practice
|
den Exter, P.L.
|
|
2012
|
129 |
S1 |
p. S183-S184
2 p.
|
artikel
|
Tijdschrift beschrijving